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Background: Crotoxin (CTX) is a potent neurotoxin
from  Crotalus  durissus  terrificus snake  venom
(CdtV) composed of two subunits: one without cata-
lytic  activity  (crotapotin),  and a basic  phospolipase
A2. Recent data have demonstrated that CdtV or CTX
inhibit some immune and inflammatory reactions.
Aim:  The  aim  of  this  paper  was  to  investigate  the
mechanisms involved in these impaired responses.
Materials  and methods: Male  Swiss mice were bled
before and at different intervals of time after subcuta-
neous  injection  of  CTX  or  bovine  serum  albumin
(BSA) (control animals). The effect of treatments on
circulating  leukocyte  mobilisation  and  on  serum
levels of interleukin (IL)-6,  IL-10, interferon (IFN)-g
and  corticosterone  were  investigated.  Spleen  cells
from  treated  animals  were  also  stimulated  in  vitro
with concanavalin A to evaluate the profile of IL-4, IL-
6,  IL-10  or  IFN-g secretion.  Cytokine  levels  were
determined by immunoenzymatic assay and corticos-
terone  levels  by  radioimmunoassay.  To  investigate
the participation of endogenous corticosteroid on the
effects  evoked  by  CTX,  animals  were  treated  with
metyrapone, an inhibitor of glucocorticoid synthesis,
previous to CTX treatment.
Results: Marked alterations on peripheral leukocyte
distribution, characterised by a drop in the number of
lymphocytes  and monocytes and an increase in the
number  of  neutrophils,  were  observed  after  CTX
injection.  No  such  alteration  was  observed  in  BSA-
treated  animals.  Increased  levels  of  IL-6,  IL-10  and
corticosterone  were  also  detected  in  CTX-injected
animals. IFN-g levels  were not  modified after  treat-
ments. In contrast, spleen cells obtained from CTX-
treated animals and stimulated with concanavalin A
secreted less IL-10 and IL-4 in comparison with cells
obtained  from  control  animals.  Metyrapone  pre-
treatment  was  effective  only  to  reverse  the  neu-
trophilia observed after CTX administration.
Conclusions: Our results suggest that CTX may con-
tribute  to  the  deficient  inflammatory  and  immune
responses induced by crude CdtV. CTX induces endog-
enous mechanisms  that  are  responsible,  at  least  in
part, for these impaired responses.
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Introduction
Crotoxin (CTX), a b -neurotoxin from the venom of
South American rattlesnake Crotalus durissus terrifi-
cus,  is  responsible  for  neuromuscular  transmission
blocking, myotoxic effects and lethality induced in
vivo by  the  venom.1,2 CTX  is  a  heterogeneous
protein, composed of a weakly toxic basic phospholi-
pase A2 (PLA2) and high enzymatic basic activity (CB),
and  an  acidic  polypeptide  devoid  of  toxic  and
enzymatic  activities,  called  crotapotin  (CA).3
Although CA is enzymatically and pharmacologically
inactive,2 it does enhance the toxicity of PLA2.4,5 On
interaction with membranes or phospholipid vesicles,
the complex dissociates: CB binds to the membrane,
and CA is released from the complex.6,7
In spite of its high PLA2 content, crude Crotalus
durissus  terrificus snake  venom  (CdtV)  induces  a
short-duration oedema,8,9 a scarce cell infiltration in
subcutaneous  tissues,  and  inhibits  some  activities
displayed  by  inflammatory  macrophages.8 In  addi-
tion,  it  has  been  demonstrated  that  CTX  or  CdtV
ISSN 0962-9351 print/ISSN 1466-1861 online/01/030125-09 © 2001 Taylor & Francis Ltd 125
DOI: 10.1080/09629350120072699
Research Paper
Mediators of Inflammation, 10, 125–133 (2001)reduces  the  humoral  immune  response to  classical
protein  antigens  without  inhibition  of  the  contact
hypersensitivity  reaction  elicited  by  sensitising
haptens.10
Inflammatory and immune responses are thought
to be regulated by cellular and vascular events that
involve a number of secreted substances. Endogenous
glucocorticoids (GCS),  whose  secretion  is  elevated
during  the  early  phase  of  the  acute  inflammatory
reaction, regulate the subsequent development of the
process  by  suppressing  both  vascular  and  cellular
events.11–13 In this context, endogenous GCS inter-
fere  with  vasodilatation  and  vascular  permeabil-
ity,14–18 leukocyte  mobilisation  and  functions,19–23
and secretion of chemical mediators.24–26 GCS also
acts on  the acquired specific  immune  response by
inhibiting T-cell activation and/or modulating synthe-
sis of Th0, Th1 and Th2 cytokines.27–30
The aim of the present study was to investigate the
role of CTX on impaired inflammatory and immune
response elicited by crude venom. In this context, the
effects of CTX on circulating leukocyte distribution
and  on  the  profile  of  pro-  and  anti-inflammatory
cytokine secretion were evaluated. In  addition, the
effect of CTX on endogenous GCS secretion and its
consequent  interference  on  effects  observed  were
also investigated. The results obtained show that in
vivo injection of CTX evokes marked alterations on
distribution of circulating leukocytes, and on cytokine
and  corticosterone secretion. CTX  treatment inhib-
ited the secretion of interleukin (IL)-4 and IL-10 by
spleen cells stimulated with concanavalin A (ConA).
The increased levels of the endogenous corticosteroid
after CTX injection interfere only with the increased
number of peripheral neutrophils. Taken together, the
data presented in this study suggest that CTX is able
to  evoke  endogenous  mechanisms,  such  as  the
reduction  of  mononuclear  cells  on  circulation  and
secretion of anti-inflammatory cytokines and gluco-
corticoids, that may  contribute to the lack of  local
inflammatory reaction during envenomation by CdtV
and  to  the  immunosuppression  evoked  by  this
venom.
Materials and methods
Animals
Male BALB/c mice weighing 18–20g were obtained
from Animal  Facilities  from  Institute  Butantan. Ani-
mals  were  allowed  a  standard  diet  and  water  ad
libitum.
Venom and purified toxin
Lyophilised  crude  CdtV  was  a  pool  obtained  from
several  specimens  of  C.  durissus  terrificus snakes
and  supplied  by  the  Laboratory  of  Herpetology,
Institute  Butantan.  CTX  was  isolated  from  crude
venom in a single-step purification process by anion-
exchange chromatography31 using a Mono-Q HR 5/5
column  in  a  FPLC  system  (Pharmacia,  Uppsala,
Sweden).  Fractions  (1ml/min)  were  eluted  by  a
linear gradient of  NaCl (0–1M  in  50 mM Tris–HCl;
pH  7.0).  Before  pooling,  fractions  containing  CTX
were  checked  for  homogeneity  by  non-reducing
sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis  (12.5%),  and  PLA2 activity  on  a  synthetic
chromogeneic substrate was assessed.
Determination of blood leukocyte counts
Blood was collected from the orbital plexus of mice
before and at varying intervals of time after subcuta-
neous  injections  of  5 m g  of  CTX  or  equivalent
concentration of bovine serum albumin (BSA) (con-
trol animals). Total leukocyte number was determined
in a Neubauer haemocitometer and differential counts
in blood smears.
Determination of immunoglobulin G1
anti-human serum albumin antibody
production
Mice  were  immunised  with  human  serum  albumin
(HSA)  plus  adjuvant  (Al(OH3);  100 m g,  subcutane-
ously)  6h  after  subcutaneous  injection  of  5 m g  of
CTX. Control animals received the same amount of
HSA  and  CTX. The  serum  immunoglobulin  (Ig)G1
anti-HSA  response  was  evaluated  by  enzyme-linked
immunosorbent  assay  (ELISA)  1  week  after  the
challenge with HSA.10 Briefly, microtitre plates, pre-
viously coated with HSA (2 m g/ml), were incubated
for 1h with different serum dilutions. After washing,
plates were incubated with peroxidase-labelled goat
anti-mouse IgG1 antibodies. The reaction was devel-
oped by the addition of substrate solution (0.4mg/ml
of  o-phenylenediamine  plus  H2O2 in  0.15M  citrate
buffer; pH 5.0). Absorbances at 492nm were recor-
ded in a microplate reader and results were expressed
as the values of absorbance given at the reciprocal of
serum dilution.
Determination of cytokine levels in serum or in
supernatant from spleen cell cultures obtained
from CTX-treated animals
Mice were subcutaneously injected with 5 m g of CTX
or BSA and blood and spleen cells were collected after
different intervals of time. Spleen cell suspensions (5 ´
106 cells/well), obtained from mice 6h after CTX or
BSA treatment, were stimulated in vitro with ConA
(5 m g/ml) for 24 or 48h at 37°C. IL-4, IL-6, IL-10 and
interferon (IFN)-g levels were determined in blood and
culture supernatant by a specific two-site sandwich
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IFN-g , XMG 1.2 and biotinylated NA 18; for IL-4, BVD-
1D11 and biotinylated BVD6–24G2; for IL-6, MP520F3
and biotinylated MP532C1L; and for IL-10, C252–2A5
and biotinylated SXC-1. Binding of biotinylated anti-
bodies was detected using streptoavidin-biotinylated
horseradish  peroxidase  (Amersham  Int.,  Uppsala,
Sweden)  and ABTS  (Sigma  Chemical Co., St. Louis,
MO,  USA)  solution  in  0.1M  citrate buffer  +  H2O2.
Samples were quantified by comparison with standard
curves  of  recombinant  mouse  cytokines.  Standard
curves  were  as  follows:  IL-4,  2.2–540pg/ml;  IL-6,
2.93–2000pg/ml;  IL-10,  30–540pg/ml;  IFN-g ,
20–1620pg/ml. All  the antibodies were purified  by
protein G-Sepharose chromatography from hybridoma
cell culture supernatants, and biotin-labelled as nee-
ded. Hybridomas and recombinant standard cytokines
were a gift from Dr R.L.  Coffman (DNAX Research
Institute, Palo Alto, CA, USA).
Determination of corticosterone levels
The effect of CTX on GCS serum levels was investi-
gated by determining the corticosterone serum con-
centration  by  radioimmunoassay  as  described  by
Abraham.32 Animals  were  treated  subcutaneously
with 5 m g  of  CTX or BSA and blood was collected
from  the  abdominal  aorta  at  varying  intervals  of
time.
Metyrapone treatment
Metyrapone (Ciba-Geigy, S˜ ao Paulo, Brazil), dissolved
in phosphate-buffered saline solution (PBS) (pH 7.2,
containing 10 mM sodium phosphate, 150 mM NaCl),
was  administered  to  block  synthesis  of  glucocor-
ticoids,  without  causing  a  typical  deficiency  of
mineralocorticoids.33 Two  daily  doses  of  30mg/kg
each were given intraperitoneally at 12h intervals for
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FIG. 1. Effect of crotoxin (CTX) on circulating leukocyte mobilisation. Blood was collected from orbital plexus of mice before
or at different intervals of time after subcutaneous injection of 5m g of CTX (d ) or equivalent concentration of bovine serum
albumin (BSA) (j ) dissolved in 100m l of sterile saline. Total leukocyte number was determined in a Neubauer haemocitometer,
and lymphocyte, monocyte or neutrophil numbers were quantified in blood smears. Values represent the mean ± SEM of six
animals in each group. * p < 0.01 in comparison with values obtained in BSA-treated animals.3 days.34 Control animals received the same amount
of PBS. The CTX treatment was initiated 2h after the
last dose and experiments were carried out according
to the procedures already described regarding leuko-
cyte mobilisation, cytokine and glucocorticoid secre-
tions, and IgG1 production.
Analysis of data
Means  and  SEM  of  all  data  are  presented  and
compared by Student’s t-test or analysis of variance.
When  appropriate,  the  data  were  analysed  by  the
Newman–Keuls test.
Results
Effects of CTX on circulating leukocyte
mobilisation
The subcutaneous injection of CTX evoked significant
alterations on the pattern of circulating  leukocytes,
without  inducing  changes  in  the  total  number  of
white cells (Fig. 1). In spite of marked alterations on
the number of polymorphonuclear and mononuclear
cells,  the values of  total leukocytes were not mod-
ified. Two hours after CTX treatment, an intense drop
in  the  number  of  lymphocytes  and  an  increase  of
neutrophils were observed. These alterations evolved
until 6–8h, when the maximal responses occurred.
Additionally,  CTX  evoked  a  drastic  drop  in  the
number of monocytes 6h after injection. Values were
normalised 24h after CTX administration (Fig. 1). No
significant alterations were observed in animals trea-
ted with BSA (Fig. 1).
Levels of serum inflammatory mediators and
endogenous glucocorticoids after in vivo CTX
treatment
Figure  2  depicts  cytokine  and  glucocorticoid  con-
centrations in  the serum of mice after CTX admin-
istration  (5 m g,  subcutaneously).  Ninety  minutes
after  CTX  injection,  a  discrete  increment  of  IL-10
was  detected  in  the  serum,  which  returned  to
basal  values  180min  after  administration.  IL-6
serum  levels  also  increased  at  180min  after  injec-
tion and remained high up to 540min. In addition,
endogenous  corticosterone  was  released  into  the
circulation  180min  after  CTX  treatment  and  the
peak  in  serum  levels  of  this  steroid  was  detected
between  6  and  9h.  In  contrast,  IFN-g levels  were
not modified after CTX injection (data not shown).
Sera obtained from control animals did not present
significant  alterations  on  the  profile  of  increments
of  the  endogenous  substances  studied  (data  not
shown).
Effect of CTX treatment on cytokine production
by spleen cells
Spleen  cells  isolated  from  mice  were  investigated
regarding  their  ability  to  secrete cytokines after  in
vitro ConA stimulation. Results presented in Figure 3
show  that  in  vivo CTX  treatment  inhibited  the
production of  IL-4 and IL-10 by  spleen cells,  when
they were stimulated for 24 or 48h. No interference
of  IL-6  or IFN-g production after  ConA stimulation
was detected.
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FIG. 2. Effects of crotoxin (CTX) on in vivo cytokine and corticosterone secretion. Animals were treated with CTX (5m g/100m l,
subcutaneously) or equivalent volume of bovine serum albumin (BSA), and blood was collected from orbital plexus at varying
intervals of time after injections. Cytokine and corticosterone serum levels were determined by enzyme-linked immunosorbent
assay and radioimmunoassay, respectively. Values represent the mean ± SD of 12 animals. (j ) IL-10 concentrations, (h ) IL-6
concentrations and (– –) corticosterone levels. * p < 0.05 in comparison with initial values and with values obtained in BSA-
treated animals. GCS, Glucocorticoids.Interference of in vivo metyrapone treatment
on effects induced by CTX
As  described,  in  vivo CTX  treatment  induces  a
significant increase in the corticosterone secretion. To
investigate the participation of this endogenous GCS
on the effects evoked by CTX, animals were treated
with metyrapone, an inhibitor of corticosteroid syn-
thesis, previous to CTX administration. The effective-
ness  of  metyrapone  treatment was  confirmed by  a
Crotoxin and inflammatory and immune reactions
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FIG. 3. Effect of in vivo crotoxin (CTX) treatment on cytokine secretion by spleen cells stimulated with concanavalin A (ConA).
Spleen cells were collected from animals 6h after bovine serum albumin (BSA) (j ) or CTX (h ) treatment. A sample of 5 ´ 10
6
cells/well were stimulated with ConA (0.5ml of 10m g/ml) during 24 or 48h at 37°C in an air chamber (5% CO2). Cytokine
contents  were  determined  by  enzyme-linked immunosorbent  assay  in  cell  supernatants.  Values  represent  the  mean  of
duplicate cultures ± SD. * p < 0.05 and ** p < 0.001 in comparison with values obtained in BSA-treated animals.
FIG. 4. Interference of metyrapone treatment on cytokine secretion induced by crotoxin (CTX). Animals were pre-treated with
metyrapone (30mg/kg, intraperitoneally; every 12h, for 3 days) or equivalent volume of phosphate-buffered saline (PBS). Two
hours after the last injections, CTX (5m g/100m l, subcutaneously) was administered. Spleen cells were collected 6h after toxin
injection, and 5 ´ 10
6 cells/well were stimulated with concanavalin A (0.5ml of 10m g/ml) during 24 or 48h at 37°C in an air
chamber (5% CO2). Cytokine levels in cell culture supernatants were determined by enzyme-linked immunosorbent assay.
Results represent the mean of duplicate cell cultures ± SD from six animals treated with PBS and CTX (h ) or with metyrapone
and CTX (j ).marked  reduction  on  corticosterone  levels  before
CTX injection (data not shown). Results showed, first,
that  metyrapone  administration  did  not  affect  the
altered  cytokine  production  by  spleen  cells  stimu-
lated with  ConA.  Cells  obtained  from  metyrapone-
and  CTX-treated  animals  produced  equivalent
amounts  of  IL-4  and  IL-10  to  those collected  from
control animals, treated with PBS and CTX (Fig. 4).
Second,  the  results  showed  that  metyrapone  treat-
ment did not interfere with the described inhibition
of IgG1 anti-HSA antibody production by CTX treat-
ment,10 performed 6h before HSA immunisation (Fig.
5). Finally, on the contrary, metyrapone pre-treatment
abolished  the  increase  in  circulating  neutrophil
counts induced by CTX, but it did not interfere with
the  distribution  of  other  leukocytes.  Numbers  of
lymphocytes and monocytes in circulating blood of
metyrapone- and CTX-treated animals were similar to
those observed in blood of animals treated with PBS
and CTX (Fig. 6).
Discussion
Class II phospholipase A2 (PLA2)  is  responsible  for
arachidonic acid mobilisation from  cell  membranes
and is believed to play a key role in inflammation.35,36
CTX,  the  most  abundant  component  of  CdtV,  is  a
complex  formed by  a non-toxic and non-enzymatic
subunit  A  and  a  venom  class  II  PLA2,  which  has
properties of lethal b -neurotoxins and exhibits high
enzymatic activity.2,37 CTX exists in several isoforms
in the same venom. It is more toxic and shows less
enzymatic  activity  than  its  dissociated  PLA2
subunit.5
It has been demonstrated that crude CdtV induces
impaired  local  inflammatory  reaction  characterised
by negligible oedema and by the absence of leukocyte
infiltration.8 Also, antibody production is impaired in
horses after CdtV administration.38
The  determination of the  total  number  of  white
blood  cells  present  in  the  circulation  provides  an
important representation of the status of activation of
the immune system and of the profile of distribution
of these cells in the organism. Marked alterations in
the number of circulating leukocytes are associated
with inflammatory reactions, which reflect mobilisa-
tion of these cells from their marginal and/or bone
marrow  pools.  Our  results  demonstrated that  CTX
injection  induces  marked  neutrophilia  and  drastic
decrease in the number of lymphocytes and mono-
cytes  at  6–8h  after  treatment. The  functional  sig-
nificance  of  these  effects  and  the  mechanisms
involved  has  not  yet  been  elucidated.  The  same
pattern  of  response  has  been  shown  during  acute
stress conditions.30,39,40 The anatomical sites where
lymphocytes and monocytes migrate from the blood
after CTX treatment are not known. No changes in the
lymphocyte numbers were detected in lymph nodes
located near to the CTX injection area or in the spleen
(data not shown). It is possible that this mononuclear
cell behaviour after CTX administration may contrib-
ute  to  the  impaired  immune  and  inflammatory
responses evoked by crude venom already described.
There  are  evidences  that  these  changes  can  sig-
nificantly alter the capacity of the immune system to
mount  an  antigen-specific-cell  mediated  immune
response in vivo.30 This hypothesis will  be  further
investigated.  The  mobilisation  of  neutrophils  into
circulation is of interest, since local injection of CTX
does not  evoke migration  of  neutrophils  to  tissues
(data not shown). Thus, it is possible that neutrophilia
may  be  secondary to  endogenous  mechanisms  eli-
cited by CTX.
The  inflammatory  and  immune  responses  are
thought to be  regulated by  a series of  cellular  and
molecular events that involve a number of cytokines.
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FIG. 5. Effect of metyrapone (MET) treatment on the inhibi-
tion of anti-human serum albumin (anti-HSA) HSA immuno-
globulin  (Ig)G  antibody  production  induced  by  crotoxin
(CTX). Animals were pre-treated with metyrapone (30mg/kg,
intraperitoneally; every 12h, for 3 days). CTX  (5m g/100m l)
was administered 2h after the last dose of metyrapone and
the mice were immunised with HSA 6h after CTX. Serum
IgG1 content was evaluated by enzyme-linked immunosor-
bent assay. Results represent the mean absorbance ± SD of
serum obtained from six animals in each group. * p < 0.05 in
comparison with values obtained in control animals, treated
with phosphate-buffered saline (PBS).Data here presented show that in vivo CTX treatment
induces  increase  in  IL-10  and  IL-6  levels  without
altering IFN-g levels in serum. On the contrary, CTX
inhibits  the production of  IL-4  and IL-10 by  spleen
cells after ConA stimulation, with no alteration of IFN-
g and IL-6 production.
IL-10  was  described originally  as  a  cytokine  pro-
duced  by  murine  Th2  clones,  which  inhibits  the
synthesis of several cytokines by Th1 clones41,42 and
decreases the proliferation and/or IL-2 production by
T cells. These effects are achieved by impairing the
expression of some co-stimulatory molecules and by
altering some functions  of professional antigen-pre-
senting cells such as macrophages.43,44 IL-10 also acts
selectively  on  the  macrophages  by  inhibiting  the
expression  of  co-stimulatory  cell  surface  B.7  mole-
cules.45,46 It has been shown that resident or inflam-
matory  macrophages  have  impaired  spreading  and
phagocytic functions after CdtV treatment.8 As macro-
phages play an important role in the innate and T-cell-
dependent  immune  responses,  it  is  proposed  that
macrophages, whose phenotype or activities could be
depressed through the early IL-10 production, might
be implicated in the depressed responses induced by
CTX.
In  agreement  with  our  results,  increased  plasma
levels of IL-6 were detected in patients bitten by C.
durissus terrificus.47 IL-6 has been found to play a
central  role  in  defence  mechanisms,  including  the
acute phase reactions, haematopoiesis and immune
response.48 Concentrations  of  IL-6  in  plasma  rise
markedly in response to tissue injury and correlates
with plasma corticosteroid hormone increments. IL-6
stimulates the hypothalamic–hypophisis–adrenal axis
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FIG. 6. Effect of metyrapone (MET) pre-treatment on leukocyte mobilisation alterations evoked by crotoxin (CTX). Animals were
pre-treated with metyrapone (30mg/kg, intraperitoneally; every 12h, for 3 days) or equivalent volume of phosphate-buffered
saline (PBS)  and, 2h  after the  last  administration, received CTX  (5m g/100m l; subcutaneously).  Before and 6h  after CTX
injection, blood was collected from the orbital plexus, and total leukocyte, lymphocyte, monocyte and neutrophil numbers
were determined. Values represent the mean ± SEM of six animals in each group. * p < 0.05 in comparison with values obtained
in control animals.inducing corticoisteroid secretion.49
Elevation of glucocorticoid levels in the circulation
is related to altered distribution of peripheral leuko-
cyte  subpopulations.  Alterations  observed  during
stress conditions, such as infection,50 are significantly
reduced  in  adrenalectomised  animals.30,40 Through
interaction with  specific  receptors,  secreted  gluco-
corticoids mediate the decrease in number of lympho-
cytes and monocytes during stress.30The lymphocyte
diminution in blood is due to retention of cells in the
lymphatic circulation.28 Indeed, neutrophilia induced
by secreted glucocorticoids is dependent on mobilisa-
tion of polymorphonuclear cells into the circulation
from the marginated and blood marrow pools.51
The elevated IL-6 levels in  serum  of  CTX-treated
animals,  and  the  observations  that  elevated  serum
glucocorticoids levels  promote alterations on white
blood  cells52 similar  to  those  evoked  by  CTX,
suggested a possible role for CTX on corticosteroid
hormone secretion. Data in the present study demon-
strate  that  CTX  induces  glucocorticoid  secretion,
reflected by elevation of corticosterone serum levels,
and corroborate the observations of Chisari et al.53
that  CdtV  or  CTX  treatments  evoke  ACTH  and
corticosterone secretion in vivo and in vitro.
Corticosteroids modulate several events related to
inflammatory and immune reactions. In this context,
vascular and cellular events of inflammatory reaction,
cytokine  secretion  and  antibody  production  are
influenced by elevated levels of corticosteroids.11–27
For these reasons, it is plausible that elevated levels of
corticosteroids after CTX injection could explain, at
least  in  part,  the  absence  of  inflammatory  effects
during human or experimental envenomation and the
impaired  IgG1 production  described. To  investigate
this  hypothesis  in  our  experimental  procedures,
animals  were  pre-treated  with  metyrapone,  a  drug
that blocks glucocorticosteroid production but does
not interfere with mineralocorticoid activity.32,33 Our
results demonstrated that pharmacological pre-treat-
ment  was  able  to  reverse  only  the  neutrophilia
evoked by CTX. All other effects were not modified,
including the inhibition of IgG antibody production.
These results indicate that the increase in corticoste-
roids was responsible for the neutrophilia, corroborat-
ing  the  hypothesis  that  the  increased  numbers  of
polymorphonuclear  cells  are  not  a  direct  effect  of
CTX,  but  instead  depend  on  the  induction  of  an
endogenous mechanism. Moreover, the elevated pro-
duction  of  endogenous  GCS  is  not  related  to  the
reduced immune response pattern induced by CTX. It
is important to emphasise that, although CTX induced
a significant elevation in serum GCS levels, such an
increment  is  still  lower  than  those  reached  when
exogenous  GCS  are  used  in  anti-inflammatory  or
immunosuppressive therapies.
Since  the  suppression  of  HSA-specific  IgG1  anti-
bodies  induced  by  CTX  was  not  related  to  the
elevated production of endogenous GCS, it could be
due  to  a  reduced  synthesis  of  IL-4  in  CTX-treated
mice. It is well known that differentiation of a Th2-
type response and IgG1 isotype switching are depend-
ent on IL-4.54 Indeed, spleen T cells obtained 6h after
CTX injection secreted much less IL-4 and IL-10, but
normal levels of IFN-g , on in vitro stimulation with
ConA. This profile of cytokine synthesis was also not
changed by the administration of the glucocorticoid
inhibitor.  These  findings  might  explain,  therefore,
why Th2-mediated  but  not Th1-mediated  responses
where affected in venom-treated mice, as previously
demonstrated by Cardoso and Mota.10 The inhibition
of  IgG1  antibody  production,  but  not  of  contact
hypersensivity,10 also discards the possibility that CTX
might induce apoptosis later in the immune response,
since  it  is known that Th1  effector  cells are much
more  susceptible  than Th2  effectors  to  this  death
mechanism.55
In  summary,  our  results  suggest  that,  despite  its
high PLA2 activity, CTX induces endogenous mecha-
nisms, evidenced by alterations on circulating leuko-
cyte  distribution  and  cytokine  and  glucocorticoid
secretion. These mechanisms may contribute to the
impaired inflammatory reaction and to the immuno-
suppression elicited by CdtV. Endogenous corticoste-
roids are not responsible for such impaired immune
response. The role of the drastic drop in circulating
mononuclear  cells  and  the  participation  of  anti-
inflammatory  cytokines  on  the  impaired  responses
elicited  in  vivo by  CTX  need  to  be  further
investigated.
D. F. Cardoso et al.
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